Publications
BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.
Note: To find a complete list of Publications, please see listing here.
Found 3 results
Filters: Author is Shi, Qian [Clear All Filters]
“International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.”, Leukemia, vol. 35, no. 1, pp. 18-30, 2021.
, “Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.”, Biol Blood Marrow Transplant, vol. 26, no. 10, pp. e247-e255, 2020.
, “Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.”, Biol Blood Marrow Transplant, vol. 26, no. 1, pp. e7-e15, 2020.
,